Aktienanalyse zu Ardent Health Inc (ARDT)ARDTArdent Health Inc

Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings. It operates in the Healthcare sector.

Ardent Health Partners Inc is a good buy right now due to its current price of $11.95, which is below the average analyst price target of $13.67, indicating potential upside. Additionally, the forward P/E ratio of 9.50 suggests the stock is undervalued compared to its earnings potential. However, the main risk is the recent EPS miss of 29.41%, which could affect investor confidence.